Overdue Milestones

I believe the reason why the share price is trending back to 52 week lows is because management is late on 6 key milestones, outlined in a presentation made at the start of 2014 (after which they shot to 52 week highs).

I shouldn't say late, because they still have 6 business days to complete their publicly stated H2 2014 milestones:

1) Signing of global APAS distribution agreement
2) Initiation of development project - Woundvue (still in research phase)
3) 4th and final $1 million APAS project
4) Commencement of APAS USA clinical trials
5) Submission of US FDA 510k for APAS
6) Renegotiation of next 3 year minimum royalty for PREVI (we need US$1.2 million plus per annum)

The market gets impatient with snail pace progress... but fingers crossed we get excellent outcomes on each of the above milestones... but we really need team LBT to work harder and execute on time.